InterVenn Biosciences, a life sciences company unlocking the value of glycoproteomics for the development of transformational healthcare solutions, and Aranscia, a global provider of award-winning ...
New at-home blood collection solution helps clinicians increase patient compliance, expand access to testing, and ...
After an over decade-long discourse amongst interested stakeholders, on October 3, 2023, FDA unveiled its proposed rule and policy to increase oversight over LDTs. If finalized as proposed, FDA would ...
For many years, success in the laboratory was defined primarily by analytical performance. While that remains essential, it ...
Food testing laboratories are facing increasing pressure to deliver fast, reliable, and defensible results across complex matrices. Expanding pesticide panels, stricter regulatory expectations, and ...
Legacy Receives New York State CLEP Approval For Two Laboratory-Developed Tests: Semen Analysis And DNA Fragmentation. Legacy clears New York's stringent pre-market review of laboratory-developed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results